|
Q4 2019
Filed on Feb 18, 2020
|
11,800
|
$73.17 - $82.23
$863K - $970K
|
|
|
Q4 2019
Filed on Feb 18, 2020
|
36,500
|
$20.51 - $24.85
$749K - $907K
|
|
|
Q4 2019
Filed on Feb 18, 2020
|
8,000
|
$49.31 - $62.35
$394K - $499K
|
|
|
Q4 2019
Filed on Feb 18, 2020
|
1,600
|
$177.95 - $194.05
$285K - $310K
|
|
|
Q4 2019
Filed on Feb 18, 2020
|
11,800
|
$84.25 - $92.4
$994K - $1.09M
|
|
|
Q4 2019
Filed on Feb 18, 2020
|
7,900
|
$116.1 - $131.69
$917K - $1.04M
|
|
|
Q4 2019
Filed on Feb 18, 2020
|
6,300
|
$137.46 - $147.11
$866K - $927K
|
|
|
Q4 2019
Filed on Feb 18, 2020
|
16,400
|
$47.39 - $63.47
$777K - $1.04M
|
|
|
Q4 2019
Filed on Feb 18, 2020
|
100,000
|
N/A
|
|
Liberty Media Corp Delaware
|
Q4 2019
Filed on Feb 18, 2020
|
100,000
|
N/A
|
|
|
Q4 2019
Filed on Feb 18, 2020
|
23,900
|
$42.07 - $46.08
$1.01M - $1.1M
|
|
Oxford Immunotec Global PLC
|
Q4 2019
Filed on Feb 18, 2020
|
137,783
|
N/A
|
|
|
Q4 2019
Filed on Feb 18, 2020
|
100,000
|
N/A
|
|
|
Q4 2019
Filed on Feb 18, 2020
|
19,445
|
$27.81 - $29.93
$541K - $582K
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
313,209
|
N/A
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
62,808
|
$9.05 - $12.22
$568K - $768K
|
|
Actinium Pharmaceuticals Inc
|
Q3 2019
Filed on Nov 12, 2019
|
168,851
|
N/A
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
110,179
|
$6.89 - $10.45
$759K - $1.15M
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
246,024
|
$3.57 - $6.58
$878K - $1.62M
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
61,483
|
$113.31 - $150.51
$6.97M - $9.25M
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
262,728
|
$24.09 - $32.18
$6.33M - $8.45M
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
809,378
|
N/A
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
14,696
|
N/A
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
29,877
|
N/A
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
197,005
|
$20.0 - $31.88
$3.94M - $6.28M
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
204,148
|
$6.42 - $9.0
$1.31M - $1.84M
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
15,700
|
$1.95 - $3.93
$30.6K - $61.7K
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
98,900
|
N/A
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
54,144
|
$42.5 - $63.11
$2.3M - $3.42M
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
132,605
|
N/A
|
|
Protalix Biotherapeutics Inc
|
Q3 2019
Filed on Nov 12, 2019
|
2,631,400
|
N/A
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
33,993
|
$9.83 - $14.82
$334K - $504K
|
|
Progenics Pharmaceuticals In
|
Q3 2019
Filed on Nov 12, 2019
|
472,580
|
N/A
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
161,877
|
N/A
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
413,154
|
$17.99 - $26.0
$7.43M - $10.7M
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
171,557
|
$16.36 - $21.39
$2.81M - $3.67M
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
145,188
|
$9.59 - $12.0
$1.39M - $1.74M
|
|
Dicerna Pharmaceuticals Inc
|
Q3 2019
Filed on Nov 12, 2019
|
188,673
|
N/A
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
97,457
|
$7.38 - $12.25
$719K - $1.19M
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
148,353
|
$10.82 - $14.25
$1.61M - $2.11M
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
581,834
|
$1.74 - $2.83
$1.01M - $1.65M
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
459,274
|
$0.64 - $0.92
$294K - $423K
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
1,000
|
$263.55 - $303.76
$264K - $304K
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
184,116
|
$3.01 - $6.5
$554K - $1.2M
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
238,248
|
$16.3 - $23.37
$3.88M - $5.57M
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
425,626
|
N/A
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
10,000,000
|
N/A
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
858,142
|
$1.75 - $2.47
$1.5M - $2.12M
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
730,228
|
N/A
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
200,559
|
$23.81 - $32.52
$4.78M - $6.52M
|
|